The EMA has revised its EudraGMP database to give the public more information on GMP inspections.
EudraGMP was launched in May 2007 but the public could only view limited information from a selection of European countries. Now, as part of its transparency initiative, the European Medicines Agency (EMA) has opened up more of the database to the public .
Anyone can now access authorisation and good manufacturing practice (GMP) certificates from all countries in the European Economic Area (EAA). The EEA consists of the European Union (EU) plus Iceland, Lichtenstein and Norway.
By opening up the database the EMA hopes to: improve information sharing between regulators and industry; support GMP certificate coordination between EU national regulators; eliminate the submission of paper forms; and provide EU inspection information to third-country regulators.